Novozymes acquires Irish-based PrecisionBiotics Group
Danish listed company Novozymes A/S has acquired the Irish based PrecisionBiotics Group to advance Novozymes' activities in the area of biological solutions for human oral and gut health - one of the growth pillars in Novozymes' strategy 'Better business with biology'. Plesner has advised Novozymes on the acquisition in collaboration with Arthur Cox.
About the transaction: Novozymes A/S has acquired 100% of the equity in PrecisionBiotics Group Limited for an amount of DKK 600 million (EUR 80 million) on a cash and debt-free basis. The transaction is structured with an earn-out model.
Plesner is proud to have advised Novozymes on the cross-border acquisition in support of its strategy 'Better business with biology'. The transaction is yet another testimony to Plesner's market leading life science practice.